Cleerly LABS vs inHEART Models
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary objective is a comprehensive, AI-powered assessment of coronary atherosclerosis and stenosis from CCTA images. This tool is ideal for clinicians focused on personalized heart disease management, risk assessment, and tracking disease progression by quantifying plaque volume and type over time.
View Cleerly LABS →Choose inHEART Models if…
Choose inHEART Models if you require highly detailed, AI-driven 3D digital twin models of the heart to optimize the planning and execution of complex cardiac ablation procedures. This tool is best suited for electrophysiologists aiming to enhance procedural efficiency and reduce recurrence rates for conditions like ventricular tachycardia through precise pre-procedural visualization and integration with electroanatomic mapping systems.
View inHEART Models →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | inHEART Models |
|---|---|---|
| Pricing | Per analysis | Contact for pricing |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Cloud-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
inHEART ModelsinHEART Models offers rapid model preparation, with user feedback indicating average wait times under twenty minutes, and a straightforward interface that is easy for even junior staff to learn. While Cleerly LABS is web-based and provides a rich diagnostic user experience, inHEART's specific positive feedback on ease of use and speed of model generation for complex procedures gives it a slight edge.
Clinical Value
inHEART ModelsinHEART Models demonstrates significant quantifiable clinical impact by potentially reducing VT procedure times by 60% and recurrence rates by 38%, and improving VT-free and overall survival in image-guided ablations. Cleerly LABS also offers strong clinical value in non-invasive CAD assessment, risk stratification, and has shown potential to reduce heart attacks by 41%, but inHEART's direct impact on complex interventional procedural outcomes is more pronounced.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing, listing a retail price and a discounted offer, along with information on insurance coverage and out-of-pocket costs. In contrast, inHEART Models' pricing is not publicly disclosed, requiring direct contact with the vendor, which can add administrative burden and hinder value assessment.
Enterprise Readiness
Cleerly LABSCleerly LABS explicitly states FDA clearance, HIPAA compliance, and the presence of a Business Associate Agreement (BAA) in its published specifications, and leverages HIPAA-compliant AWS offerings. While inHEART Models is FDA-cleared and its SOC2 compliance suggests a strong focus on data security, explicit confirmation of BAA and HIPAA compliance was not found in the provided facts or search results, giving Cleerly a clearer advantage in explicit enterprise readiness.
Innovation
inHEART ModelsinHEART Models' creation of highly detailed, AI-driven 'digital twin' models of the heart for optimizing cardiac ablation planning and execution represents a cutting-edge application in interventional cardiology. Cleerly LABS is also innovative in its comprehensive, AI-powered quantitative plaque analysis for personalized CAD management, but the 'digital twin' concept for surgical guidance is arguably more transformative for its specific domain.
Support & Docs
Cleerly LABSCleerly LABS explicitly outlines its customer support availability, operating Monday through Friday with a commitment to responding to after-hours needs as a first priority. It also provides a dedicated client support form for existing users. No comparable specific details regarding support hours or dedicated documentation were found for inHEART Models.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | inHEART Models |
|---|---|---|
| Name | Cleerly LABS | inHEART Models |
| Company | Cleerly | inHEART |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures. |
| Key Features | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy | AI-driven digital twin of the heart, Automated segmentation of CT and MR images, Highly detailed, interactive 3D cardiac models, Pre-procedural planning and optimization of treatment strategies, Seamless integration with major electroanatomic mapping (EAM) systems (Cartou00ae, Rhythmiau2122, Ensiteu2122, Afferau2122), Potential to reduce VT procedure times by 60%, Potential to reduce VT recurrence rates by 38%, Cloud-based platform for interactive exploration |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and inHEART Models.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or inHEART Models
Backers
Who funded each tool's parent company.